UNIVERSITY OF EDINBURGH

Hellenic Dynamics delays €1m loan, affecting stock suspension and FY24 results. Ananda Developments partners with Australian firm for MRX1 CBD trials. Flora Growth expands in Germany via Flowzz.com partnership.

CheekAge, a new epigenetic clock, uses cheek cell methylation data to predict mortality risk, outperforming blood-based models and suggesting a noninvasive method for monitoring aging.

New UK-created cancer therapies to be trialled, benefiting NHS patients through partnerships with pharmaceutical companies and universities. Innovations include AI for early cancer detection and flexible medical scanners, aiming to transform treatment and boost the UK's life sciences industry.

Ananda Developments plc announces Prof. Marie Fallon joining its Scientific Advisory Board to provide expert advice on CBD-based therapies for inflammatory pain conditions. Fallon leads Ananda's Phase II study on MRX1 for Chemotherapy Induced Peripheral Neuropathy.

Resolution Therapeutics, co-founded by Syncona in 2020, raised £63.5 million in Series B financing to progress RTX001, an engineered autologous macrophage cell therapy for end stage liver disease. The company plans to start a phase 1/2 EMERALD trial in the UK and Spain by year-end, aiming to regenerate liver tissue and explore other regenerative therapies.

CheekAge, a new test analyzing cheek cell DNA methylation, may predict life span. Developed by Tally Health, it identifies epigenetic markers linked to mortality, outperforming blood-based tests. A simple cheek swab could offer a noninvasive alternative for aging studies.

Charles Cockell proposes using bioengineered microbes to process organic materials on the moon, Mars, and beyond, turning them into industrial feedstocks for space colonies, potentially accelerating space exploration.

A study in PLOS Biology suggests that despite higher mutation rates and reduced natural selection in humans, the accumulation of damaging mutations is unlikely to significantly impact human fitness in the near future, with overexploitation of resources being a greater concern.

2008 saw the iLimb, the first multi-articulating prosthetic hand. In 2013, Edinburgh's Heriot-Watt University pioneered 3D printing of stem cell clusters for organ creation. 2014 featured rapid meningitis diagnosis via SERS and stem cell-derived human liver tissue. Scottish scientists contributed to COVID-19 vaccine development and Parkinson's research, with 2024 revealing a molecular switch's role in protecting against Parkinson's. Scotland's medical innovations span centuries, from the Monro dynasty to modern AI and stem cell research.